- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 498/08 - Bridged systems
Patent holdings for IPC class C07D 498/08
Total number of patents in this class: 959
10-year publication summary
|
65
|
78
|
68
|
77
|
95
|
68
|
63
|
91
|
80
|
20
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2961 |
39 |
| VALO Health, Inc. | 147 |
32 |
| Bristol-myers Squibb Company | 5080 |
29 |
| Janssen Pharmaceutica N.V. | 3839 |
24 |
| Amgen Inc. | 3779 |
21 |
| Bayer Pharma AG | 1096 |
20 |
| Novartis AG | 11238 |
18 |
| F. Hoffmann-La Roche AG | 7958 |
18 |
| Merck Sharp & Dohme LLC | 3689 |
18 |
| Boehringer Ingelheim International GmbH | 4629 |
16 |
| Bayer AG | 3045 |
16 |
| AstraZeneca AB | 3042 |
14 |
| Vertex Pharmaceuticals Incorporated | 1581 |
14 |
| Pfizer Inc. | 3322 |
12 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
12 |
| Enanta Pharmaceuticals, Inc. | 420 |
11 |
| Heptares Therapeutics Limited | 225 |
11 |
| Merck Patent GmbH | 5909 |
10 |
| Purdue Pharma L.P. | 519 |
10 |
| Theravance Biopharma R&D IP, LLC | 550 |
10 |
| Other owners | 604 |